Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-10.22
Price to sales ratio
0.87
Dividends per share
0.52
Dividend yield %
2.72

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
758
SOLV
Solventum Corporation Common Stock
77.42 USD+0.93%-1.61%-3.19%+1.59%13.41 B USD
772
ALGN
Align Technology, Inc. - Common Stock
180.59 USD+0.64%-4.76%+1.52%-4.94%12.93 B USD
1024
RGEN
Repligen Corporation - Common Stock
144.88 USD+0.44%+0.21%+8.35%-12.56%8.17 B USD
1035
ATR
AptarGroup, Inc. Common Stock
124.90 USD-0.51%-1.51%+5.72%-20.69%7.97 B USD

Frequently asked questions about Baxter International Inc. Common Stock

What is the Baxter International Inc. Common Stock stock price today?

The current price of Baxter International Inc. Common Stock (BAX) is 22.59. Over the past 24 hours, the stock has changed by -0.13%. Follow the BAX chart for real-time price dynamics.

What is the stock ticker of Baxter International Inc. Common Stock?

Baxter International Inc. Common Stock trades under the ticker BAX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Baxter International Inc. Common Stock stock going up?

BAX has changed by -1.91% over the last week, +7.01% over the last month, and -21.43% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Baxter International Inc. Common Stock release financial reports?

Yes. You can track Baxter International Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Baxter International Inc. Common Stock net income for the last quarter?

Baxter International Inc. Common Stock reported net income of -15 M for the last quarter. The previous quarter showed -1.13 B, which means net income changed by +98.67%.

How many employees does Baxter International Inc. Common Stock have?

As of the latest available data, Baxter International Inc. Common Stock has 37.5 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Baxter International Inc. Common Stock EBITDA?

Baxter International Inc. Common Stock EBITDA is 52 M, and its EBITDA margin is 1.93%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Baxter International Inc. Common Stock stock?

You can buy Baxter International Inc. Common Stock (BAX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Baxter International Inc. Common Stock stock?

Investing in Baxter International Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BAX chart and related analysis on metatrader.com as part of your research.

Baxter International Inc. Common Stock

Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals. Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients. Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services". Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology.

News